Provided by Tiger Trade Technology Pte. Ltd.

Brainsway Ltd.

14.74
-0.2300-1.54%
Post-market: 14.740.00000.00%19:30 EDT
Volume:47.35K
Turnover:699.74K
Market Cap:590.09M
PE:61.75
High:15.16
Open:14.85
Low:14.68
Close:14.97
52wk High:17.40
52wk Low:7.14
Shares:40.03M
Float Shares:24.07M
Volume Ratio:0.43
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2387
EPS(LYR):0.1822
ROE:12.82%
ROA:4.05%
PB:7.45
PE(LYR):80.89

Loading ...

Company Profile

Company Name:
Brainsway Ltd.
Exchange:
NASDAQ
Establishment Date:
2003
Employees:
129
Office Location:
16 Hartum St,Har Hotzvim,Jerusalem,Israel
Zip Code:
9777516
Fax:
- -
Introduction:
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Directors

Name
Position
Ami Boehm
Chairman of the Board
David Zacut
Vice Chairman of the Board
Abraham Zangen
Director
Avner Lushi
Director
Eti Mitrany
Director
Jonathan Shulkin
Director
Karen Sarid
Director

Shareholders

Name
Position
Hadar Levy
Chief Executive Officer
Ido Marom
Chief Financial Officer
Colleen Hanlon
Vice President of Medical Affairs
Gilead Moiseyev
Chief Technology Officer
Naomi Rozenfeld
Chief Marketing Officer
Yiftach Roth
Chief Scientist